Rifalazil Retains Activity Against Rifampin-resistant Mutants of Chlamydia pneumoniae
スポンサーリンク
概要
- 論文の詳細を見る
- 2008-08-25
著者
-
Murphy Christopher
Activbiotics Inc.
-
Rothstein David
Activbiotics Inc.
-
SUCHLAND Robert
Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington
-
XIA Minsheng
Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington
-
STAMM Walter
Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington
-
Xia Minsheng
Division Of Allergy And Infectious Diseases Department Of Medicine University Of Washington
-
Suchland Robert
Division Of Allergy And Infectious Diseases Department Of Medicine University Of Washington
-
Stamm Walter
Division Of Allergy And Infectious Diseases Department Of Medicine University Of Washington
関連論文
- Rifalazil and Derivative Compounds Show Potent Efficacy in a Mouse Model of H. pylori Colonization
- In Vitro Activity of Novel Rifamycins against Gram-positive Clinical Isolates
- Rifalazil Retains Activity Against Rifampin-resistant Mutants of Chlamydia pneumoniae
- Enhanced Activity of Rifalazil in Combination with Levofloxacin, Linezolid, or Mupirocin against Staphylococcus aureus In Vitro
- In Vitro Time-kill Activities of Rifalazil, Alone and in Combination with Vancomycin, against Logarithmic and Stationary Cultures of Staphylococcus aureus